Adimmune Corp (國光生技), a Taiwanese vaccine developer, said on Tuesday that it is scheduled to list on the Taiwan Stock Exchange (TWSE) on May 3.
According to a prospectus posted on the exchange’s Web site, the company, which was established in 1965 and is capitalized at NT$1.64 billion (US$55.59 million), is planning to issue 19.53 million shares to raise about NT$976.50 million in working capital.
While Adimmune has set a tentative issue price of NT$50 for the shares, market analysts said the actual price is expected to range between NT$40 and NT$43.
Adimmune, which is the only vaccine manufacturer in Asia to have obtained GMP (Good Manufacturing Practice) certification from the EU, specializes in the development of vaccines for influenza, Japanese encephalitis and tetanus.
Adimmune has teamed up with Dutch-based biotech company Crucell, the world’s sixth-largest flu vaccine manufacturer, for technological cooperation, while it has also partnered with Japan’s largest flu vaccine developer, the Kitasato Institute.
Crucell is one of the company’s majority shareholders, with an 11.39 percent stake, according to the prospectus.
Adimmune chairman Steve Chan (詹啟賢) told investors that the company completed animal testing for an H5N1 avian flu vaccine at the end of last year and is expected to begin human testing this year.
In addition, Chan said the company’s enterovirus 71 vaccine, which is undergoing clinical trials, is scheduled to hit the market in 2017, while a dengue fever vaccine is expected to be launched in 2019.
Last year, the company sold about 1.5 million flu vaccine doses in Taiwan, taking a 55 percent share of the domestic flu vaccine market. The company expects its market share to fall to about 50 percent this year.
In addition, it anticipates it will be granted permits to sell flu vaccine in China at the end of this year at the earliest.
Adimmune posted NT$290 million in sales last year, but incurred a NT$2.87 net loss per share because of an unsatisfactory capacity utilization rate.
However, on the back of rising production, its capacity utilization rate is expected to range between 70 percent and 80 percent in the second half of this year and it is likely to exceed 90 percent next year, which will improve its bottom line, the company said.
ASE Technology Holding Co (ASE, 日月光投控) yesterday launched its second testing facility in San Jose, California, to expand advanced chip testing capacity such as burn-in testing to satisfy customers’ rising engineering needs for emerging semiconductor applications, such as artificial intelligence (AI) and high-performance computing (HPC). ISE Labs Inc, a fully owned subsidiary of ASE, would operate the advanced testing facility. When added to its first facility in nearby Fremont, ISE would double its available research-and-development lab and business space to 150,000m2 in hopes of boosting the US semiconductor supply chain, the company said in a statement. “As the semiconductor manufacturing supply chain reshoring
VALUE: TSMC’s market capitalization far exceeds the combined size of all the Latin American companies on MSCI Inc’s benchmark for emerging markets Taiwan Semiconductor Manufacturing Co’s (TSMC, 台積電) US$420 billion equity rally this year would get a valuation test this week when it reports earnings, with analysts expecting the chipmaker to raise full-year sales forecasts. The world’s biggest contract chipmaker would probably report a 29 percent increase in second-quarter net income on Thursday, according to the median estimate of analysts surveyed by Bloomberg. More importantly, analysts from JPMorgan Chase & Co to Morgan Stanley expect it to also raise its full-year sales guidance, justifying another round of valuation expansion. Just like Nvidia Corp, TSMC has become a favorite artificial intelligence (AI)-bet for investors with
ASSASSINATION ATTEMPT: The previous shooting targeting a US president or major party candidate was the 1981 incident targeting then-US president Ronald Reagan Saturday’s shooting at former US president Donald Trump’s election rally raises his odds of winning back the White House, and trades betting on his victory would increase this coming week, investors said yesterday. Trump was shot in the ear during the rally in Pennsylvania on Saturday in what the authorities were treating as an assassination attempt. Trump, his face spattered with blood, pumped his fist moments after the attack, and his campaign said he was fine after the incident. Before the shooting, markets had reacted to the prospect of a Trump presidency by pushing the US dollar higher and positioning for a
President William Lai (賴清德) yesterday thanked memory chipmaker Micron Technology CEO Sanjay Mehrotra for his trust and continued investment in Taiwan, in a rare public meeting with a senior foreign tech executive. It is very unusual for Taiwan’s president to have publicized meetings with senior foreign tech executives, despite the nation being home to the world’s largest contract chipmaker, Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), whose chips help to power the surge in artificial intelligence (AI) applications. Lai thanked Mehrotra for “showing trust and support for Taiwan” in a video released by the Presidential Office. “I want to thank Micron for its long-term